NeoGenomics, Inc. (NEO) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqCM. Market cap 2.09B USD. 52-week range 7.07 to 20.15 USD. Data as of 2026-10-09.
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the ...